The first 1000 symptomatic pediatric SARS-CoV-2 infections in an integrated health care system: a prospective cohort study

Abstract Background The spectrum of illness and predictors of severity among children with SARS-CoV-2 infection are incompletely understood. Methods Active surveillance was performed for SARS-CoV-2 by polymerase chain reaction among symptomatic pediatric patients in a quaternary care academic hospit...

Full description

Bibliographic Details
Main Authors: Leigh M. Howard, Kathryn Garguilo, Jessica Gillon, Kerry LeBlanc, Adam C. Seegmiller, Jonathan E. Schmitz, Daniel W. Byrne, Henry J. Domenico, Ryan P. Moore, Steven A. Webber, Natasha B. Halasa, Ritu Banerjee
Format: Article
Language:English
Published: BMC 2021-09-01
Series:BMC Pediatrics
Online Access:https://doi.org/10.1186/s12887-021-02863-1
id doaj-dd3645a8af1c4e289f26546dd99dc9b3
record_format Article
spelling doaj-dd3645a8af1c4e289f26546dd99dc9b32021-09-19T11:47:06ZengBMCBMC Pediatrics1471-24312021-09-012111910.1186/s12887-021-02863-1The first 1000 symptomatic pediatric SARS-CoV-2 infections in an integrated health care system: a prospective cohort studyLeigh M. Howard0Kathryn Garguilo1Jessica Gillon2Kerry LeBlanc3Adam C. Seegmiller4Jonathan E. Schmitz5Daniel W. Byrne6Henry J. Domenico7Ryan P. Moore8Steven A. Webber9Natasha B. Halasa10Ritu Banerjee11Department of Pediatrics, Vanderbilt University Medical CenterDepartment of Pediatrics, Vanderbilt University Medical CenterDepartment of Pediatrics, Vanderbilt University Medical CenterDepartment of Pediatrics, Vanderbilt University Medical CenterDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical CenterDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical CenterDepartment of Biostatistics, Vanderbilt University Medical CenterDepartment of Biostatistics, Vanderbilt University Medical CenterDepartment of Biostatistics, Vanderbilt University Medical CenterDepartment of Pediatrics, Vanderbilt University Medical CenterDepartment of Pediatrics, Vanderbilt University Medical CenterDepartment of Pediatrics, Vanderbilt University Medical CenterAbstract Background The spectrum of illness and predictors of severity among children with SARS-CoV-2 infection are incompletely understood. Methods Active surveillance was performed for SARS-CoV-2 by polymerase chain reaction among symptomatic pediatric patients in a quaternary care academic hospital laboratory beginning March 12, 2020. We obtained sociodemographic and clinical data 5 (+/-3) and 30 days after diagnosis via phone follow-up and medical record review. Logistic regression was used to assess predictors of hospitalization. Results The first 1000 symptomatic pediatric patients were diagnosed in our institution between March 13, 2020 and September 28, 2020. Cough (52 %), headache (43 %), and sore throat (36 %) were the most common symptoms. Forty-one (4 %) were hospitalized; 8 required ICU admission, and 2 required mechanical ventilation (< 1 %). One patient developed multisystem inflammatory syndrome in children; one death was possibly associated with SARS-CoV-2 infection. Symptom resolution occurred by follow-up day 5 in 398/892 (45 %) patients and by day 30 in 443/471 (94 %) patients. Pre-existing medical condition (OR 7.7; 95 % CI 3.9–16.0), dyspnea (OR 6.8; 95 % CI 3.2–14.1), Black race or Hispanic ethnicity (OR 2.7; 95 % CI 1.3–5.5), and vomiting (OR 5.4; 95 % CI 1.2–20.6) were the strongest predictors of hospitalization. The model displayed excellent discriminative ability (AUC = 0.82, 95 % CI 0.76–0.88, Brier score = 0.03). Conclusions In 1000 pediatric patients with systematic follow-up, most SARS-CoV-2 infections were mild, brief, and rarely required hospitalization. Pediatric predictors of hospitalization included comorbid conditions, Black race, Hispanic ethnicity, dyspnea and vomiting and were distinct from those reported among adults.https://doi.org/10.1186/s12887-021-02863-1
collection DOAJ
language English
format Article
sources DOAJ
author Leigh M. Howard
Kathryn Garguilo
Jessica Gillon
Kerry LeBlanc
Adam C. Seegmiller
Jonathan E. Schmitz
Daniel W. Byrne
Henry J. Domenico
Ryan P. Moore
Steven A. Webber
Natasha B. Halasa
Ritu Banerjee
spellingShingle Leigh M. Howard
Kathryn Garguilo
Jessica Gillon
Kerry LeBlanc
Adam C. Seegmiller
Jonathan E. Schmitz
Daniel W. Byrne
Henry J. Domenico
Ryan P. Moore
Steven A. Webber
Natasha B. Halasa
Ritu Banerjee
The first 1000 symptomatic pediatric SARS-CoV-2 infections in an integrated health care system: a prospective cohort study
BMC Pediatrics
author_facet Leigh M. Howard
Kathryn Garguilo
Jessica Gillon
Kerry LeBlanc
Adam C. Seegmiller
Jonathan E. Schmitz
Daniel W. Byrne
Henry J. Domenico
Ryan P. Moore
Steven A. Webber
Natasha B. Halasa
Ritu Banerjee
author_sort Leigh M. Howard
title The first 1000 symptomatic pediatric SARS-CoV-2 infections in an integrated health care system: a prospective cohort study
title_short The first 1000 symptomatic pediatric SARS-CoV-2 infections in an integrated health care system: a prospective cohort study
title_full The first 1000 symptomatic pediatric SARS-CoV-2 infections in an integrated health care system: a prospective cohort study
title_fullStr The first 1000 symptomatic pediatric SARS-CoV-2 infections in an integrated health care system: a prospective cohort study
title_full_unstemmed The first 1000 symptomatic pediatric SARS-CoV-2 infections in an integrated health care system: a prospective cohort study
title_sort first 1000 symptomatic pediatric sars-cov-2 infections in an integrated health care system: a prospective cohort study
publisher BMC
series BMC Pediatrics
issn 1471-2431
publishDate 2021-09-01
description Abstract Background The spectrum of illness and predictors of severity among children with SARS-CoV-2 infection are incompletely understood. Methods Active surveillance was performed for SARS-CoV-2 by polymerase chain reaction among symptomatic pediatric patients in a quaternary care academic hospital laboratory beginning March 12, 2020. We obtained sociodemographic and clinical data 5 (+/-3) and 30 days after diagnosis via phone follow-up and medical record review. Logistic regression was used to assess predictors of hospitalization. Results The first 1000 symptomatic pediatric patients were diagnosed in our institution between March 13, 2020 and September 28, 2020. Cough (52 %), headache (43 %), and sore throat (36 %) were the most common symptoms. Forty-one (4 %) were hospitalized; 8 required ICU admission, and 2 required mechanical ventilation (< 1 %). One patient developed multisystem inflammatory syndrome in children; one death was possibly associated with SARS-CoV-2 infection. Symptom resolution occurred by follow-up day 5 in 398/892 (45 %) patients and by day 30 in 443/471 (94 %) patients. Pre-existing medical condition (OR 7.7; 95 % CI 3.9–16.0), dyspnea (OR 6.8; 95 % CI 3.2–14.1), Black race or Hispanic ethnicity (OR 2.7; 95 % CI 1.3–5.5), and vomiting (OR 5.4; 95 % CI 1.2–20.6) were the strongest predictors of hospitalization. The model displayed excellent discriminative ability (AUC = 0.82, 95 % CI 0.76–0.88, Brier score = 0.03). Conclusions In 1000 pediatric patients with systematic follow-up, most SARS-CoV-2 infections were mild, brief, and rarely required hospitalization. Pediatric predictors of hospitalization included comorbid conditions, Black race, Hispanic ethnicity, dyspnea and vomiting and were distinct from those reported among adults.
url https://doi.org/10.1186/s12887-021-02863-1
work_keys_str_mv AT leighmhoward thefirst1000symptomaticpediatricsarscov2infectionsinanintegratedhealthcaresystemaprospectivecohortstudy
AT kathryngarguilo thefirst1000symptomaticpediatricsarscov2infectionsinanintegratedhealthcaresystemaprospectivecohortstudy
AT jessicagillon thefirst1000symptomaticpediatricsarscov2infectionsinanintegratedhealthcaresystemaprospectivecohortstudy
AT kerryleblanc thefirst1000symptomaticpediatricsarscov2infectionsinanintegratedhealthcaresystemaprospectivecohortstudy
AT adamcseegmiller thefirst1000symptomaticpediatricsarscov2infectionsinanintegratedhealthcaresystemaprospectivecohortstudy
AT jonathaneschmitz thefirst1000symptomaticpediatricsarscov2infectionsinanintegratedhealthcaresystemaprospectivecohortstudy
AT danielwbyrne thefirst1000symptomaticpediatricsarscov2infectionsinanintegratedhealthcaresystemaprospectivecohortstudy
AT henryjdomenico thefirst1000symptomaticpediatricsarscov2infectionsinanintegratedhealthcaresystemaprospectivecohortstudy
AT ryanpmoore thefirst1000symptomaticpediatricsarscov2infectionsinanintegratedhealthcaresystemaprospectivecohortstudy
AT stevenawebber thefirst1000symptomaticpediatricsarscov2infectionsinanintegratedhealthcaresystemaprospectivecohortstudy
AT natashabhalasa thefirst1000symptomaticpediatricsarscov2infectionsinanintegratedhealthcaresystemaprospectivecohortstudy
AT ritubanerjee thefirst1000symptomaticpediatricsarscov2infectionsinanintegratedhealthcaresystemaprospectivecohortstudy
AT leighmhoward first1000symptomaticpediatricsarscov2infectionsinanintegratedhealthcaresystemaprospectivecohortstudy
AT kathryngarguilo first1000symptomaticpediatricsarscov2infectionsinanintegratedhealthcaresystemaprospectivecohortstudy
AT jessicagillon first1000symptomaticpediatricsarscov2infectionsinanintegratedhealthcaresystemaprospectivecohortstudy
AT kerryleblanc first1000symptomaticpediatricsarscov2infectionsinanintegratedhealthcaresystemaprospectivecohortstudy
AT adamcseegmiller first1000symptomaticpediatricsarscov2infectionsinanintegratedhealthcaresystemaprospectivecohortstudy
AT jonathaneschmitz first1000symptomaticpediatricsarscov2infectionsinanintegratedhealthcaresystemaprospectivecohortstudy
AT danielwbyrne first1000symptomaticpediatricsarscov2infectionsinanintegratedhealthcaresystemaprospectivecohortstudy
AT henryjdomenico first1000symptomaticpediatricsarscov2infectionsinanintegratedhealthcaresystemaprospectivecohortstudy
AT ryanpmoore first1000symptomaticpediatricsarscov2infectionsinanintegratedhealthcaresystemaprospectivecohortstudy
AT stevenawebber first1000symptomaticpediatricsarscov2infectionsinanintegratedhealthcaresystemaprospectivecohortstudy
AT natashabhalasa first1000symptomaticpediatricsarscov2infectionsinanintegratedhealthcaresystemaprospectivecohortstudy
AT ritubanerjee first1000symptomaticpediatricsarscov2infectionsinanintegratedhealthcaresystemaprospectivecohortstudy
_version_ 1717375547077558272